Purification of CD34+ Cells From the BM and Leukapheresis Products of Healthy Donors Treated With rhG-CSF
| Source of Cells . | % Start . | % Purity . | % Recovery . | Enrichment Factor . |
|---|---|---|---|---|
| PB (D5) | 0.7 ± 0.4 | 98.9 ± 0.8 | 90 ± 7.7 | 137 ± 46 |
| BM (D0) | 2.5 ± 1* | 95 ± 6 | 87.9 ± 15 | 57 ± 28* |
| BM (D5) | 2.1 ± 1* | 96 ± 4 | 88 ± 12 | 57 ± 22* |
| Source of Cells . | % Start . | % Purity . | % Recovery . | Enrichment Factor . |
|---|---|---|---|---|
| PB (D5) | 0.7 ± 0.4 | 98.9 ± 0.8 | 90 ± 7.7 | 137 ± 46 |
| BM (D0) | 2.5 ± 1* | 95 ± 6 | 87.9 ± 15 | 57 ± 28* |
| BM (D5) | 2.1 ± 1* | 96 ± 4 | 88 ± 12 | 57 ± 22* |
The results are expressed as the mean ± SD of 26 experiments (BM = 10).
Statistically significant compared with PB samples.